Neoadjuvant followed by adjuvant pembrolizumab in melanoma: time biases in the data analysis of the SWOG S1801 trial.

Skip to main content

Open Access Publications from the University of California

Neoadjuvant followed by adjuvant pembrolizumab in melanoma: time biases in the data analysis of the SWOG S1801 trial.

2024

Published Web Location

https://www.sciencedirect.com/science/article/pii/S193652332400086X?via%3Dihub

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.